National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
 
 
Results: 1 -10 of 30         results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

   
Phase III

   
EORTC-18021
EUDRACT-2004-002245-12, NCT00110123

 
 
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

   
Phase III

   
NCI-06-C-0088
NCI-P6701, NCT00324727

 
 
Lucentis as an Adjuvanct Therapy With TTT-ICG Based in Choroidal Melanoma

   
Phase III

   
FVF4290s
NCT00680225

 
 
Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC

   
Phase III

   
101.321-13/07
EudraCT Nr. 2008-001686-28, NCT00779714

 
 
Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma

   
Phase II, Phase I

   
NU-05M1
NU-0310-093, SPRI-NU-05M1, NCT00301067

 
 
Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma

   
Phase II, Phase I

   
MCC-13649
LAC-USC-10M-05-2, 6241, NCI-6241, LAC-USC-HS-05-00068, NCT00313508

 
 
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

   
Phase II

   
MCC-15241
MDX-010-16, NCI-6446, 6446, NCT00084656, LAC-USC-10M036

 
 
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

   
Phase II

   
NCI-04-C-0273
NCI-6332, DELCATH-G990039, NCT00096083

 
 
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

   
Phase II

   
MSKCC-05122
NCT00445965

 
 
VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

   
Phase II

   
CCC-PHII-77
7522, NCT00450255

 
      1 2 3   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov